Zasocitinib (Dose A) — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2027-02-05 in 3mo
ESTIMATED |
READOUT
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Phase 2 · Hidradenitis Suppurativa |
TAK TAKEDA PHARMACEUTICAL CO LTD | Zasocitinib (Dose A) |
ClinicalTrials.gov ↗
✓ Source-checked 2026-11-05
Sponsor-projected date — can change
|